The following are some of the stocks that moved up in after-hours trading on Wednesday.
Avalo Therapeutics Inc. (AVTX) has acquired a phase II-ready anti-IL-1ß mAb, which it refers to as AVTX-009, through the acquisition of privately held AlmataBio Inc. AVTX-009 will be explored in the indication of hidradenitis suppurativa and topline results from a planned phase II trial in hidradenitis suppurativa are expected in 2026.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.